Hydroxychloroquine
Hydroxychloroquine is a pharmaceutical drug with 277 clinical trials. Currently 31 active trials ongoing. Historical success rate of 67.7%.
Success Metrics
Based on 113 completed trials
Phase Distribution
Phase Distribution
57
Early Stage
87
Mid Stage
96
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
59.5%
113 of 190 finished
40.5%
77 ended early
31
trials recruiting
277
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydroxychloroquine as Treatment in Untreated Pancreas Cancer
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Trial of Treatments for COVID-19 in Hospitalized Adults
Testing Dabrafenib and Trametinib With or Without Hydroxychloroquine in Stage IIIC or IV BRAF V600E/K Melanoma
CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer
Clinical Trials (277)
Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydroxychloroquine as Treatment in Untreated Pancreas Cancer
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Trial of Treatments for COVID-19 in Hospitalized Adults
Testing Dabrafenib and Trametinib With or Without Hydroxychloroquine in Stage IIIC or IV BRAF V600E/K Melanoma
CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer
Study of Hydroxychloroquine With FOLFIRI and Bevacizumab in DTP-high Metastatic Colorectal Cancer
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer
The Danish Pre-HCQ COVID Dialysis Study
Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer
Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory Osteosarcoma
Hydroxychloroquine in ANCA Vasculitis Evaluation
Randomised Evaluation of COVID-19 Therapy
Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma
Study of the Efficiency of Hydroxychloroquine on the Endothelial Dysfunction and Its Vascular Consequences During the Antiphospholipid Syndrome
PaTcH Study: A Phase 2 Study of Trametinib and Hydroxychloroquine in Patients With Metastatic Refractory Pancreatic Cancer
Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer
Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 277